2/22/22 16:05 | 2/17/22 | TYME | Health | Drug | Pharmaceutical Preparations | Van Tornout Jan M | NJ | O | Acting C | P | 3 | 0.3600 | 0 | 7 | 250 | 10 | D | | | | | | | | | | | | | | |
2/16/22 16:05 | 2/15/22 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NJ | O | GC | P | 7 | 0.3400 | 0 | 20 | 23 | 105 | D | | | | | | | | | | | | | | |
12/27/21 16:05 | 12/23/21 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NJ | O | GC | P | 7 | 0.6500 | 0 | 10 | 13 | 85 | D | | | | | | | | | | | | | | |
11/15/21 16:51 | 11/12/21 | TYME | Health | Drug | Pharmaceutical Preparations | Galaini Barbara | NJ | O | See Rema | P | 10 | 0.9500 | 0 | 10 | 100 | 20 | D | | | | | | | | | | | | | | |
11/15/21 16:49 | 11/12/21 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NJ | O | GC | P | 10 | 0.9500 | 0 | 10 | 15 | 75 | D | | | | | | | | | | | | | | |
11/15/21 16:48 | 11/12/21 | TYME | Health | Drug | Pharmaceutical Preparations | Porfido Frank L. | NJ | O | CFO | P | 9 | 0.9300 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
9/23/21 16:05 | 9/22/21 | TYME | Health | Drug | Pharmaceutical Preparations | Carberry David | NJ | D | | P | 52 | 1.03 | 0 | 50 | 100 | 100 | D | | | | | | | | | | | | | | |
9/23/21 16:05 | 9/22/21 | TYME | Health | Drug | Pharmaceutical Preparations | Carberry David | NJ | D | | P | 52 | 1.03 | 0 | 50 | 100 | 100 | D | | | | | | | | | | | | | | |
8/16/21 16:05 | 8/12/21 | TYME | Health | Drug | Pharmaceutical Preparations | Van Tornout Jan M | NJ | O | Acting C | P | 1 | 1.05 | 0 | 1 | 55 | 3 | D | | | | | | | | | | | | | | |
4/14/21 21:39 | 4/5/21 | TYME | Health | Drug | Pharmaceutical Preparations | Van Tornout Jan M | NJ | O | Acting C | P.m | 3 | 1.81 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
9/3/20 16:19 | 9/1/20 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NJ | O | GC | P | 10 | 0.9500 | 0 | 10 | 18 | 65 | D | | | | | | | | | | | | | | |
9/3/20 16:18 | 9/1/20 | TYME | Health | Drug | Pharmaceutical Preparations | Michels Douglas A | NJ | D | | P | 48 | 0.9600 | 0 | 50 | 83 | 110 | D | | | | | | | | | | | | | | |
3/20/20 16:18 | 3/18/20 | TYME | Health | Drug | Pharmaceutical Preparations | Carberry David | NY | D | | P | 19 | 0.9500 | 0 | 20 | 67 | 50 | D | | | | | | | | | | | | | | |
3/20/20 16:15 | 3/18/20 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NY | O | GC | P | 9 | 0.9100 | 0 | 10 | 22 | 55 | D | | | | | | | | | | | | | | |
11/18/19 16:13 | 11/15/19 | TYME | Health | Drug | Pharmaceutical Preparations | Hoffman Steve | NY | DOT | CEO | P | 10 | 1.03 | 0 | 10 | 0 | 26,493 | D | | | | | | | | | | | | | | |
11/18/19 16:11 | 11/15/19 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NY | O | GC | P | 11 | 1.05 | 0 | 10 | 28 | 45 | D | | | | | | | | | | | | | | |
6/18/19 08:00 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Biehl James | NY | O | GC | P | 16 | 1.06 | 0 | 15 | 74 | 35 | D | | | | | | | | | | | | | | |
6/18/19 08:00 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Carberry David | NY | D | | P | 32 | 1.07 | 0 | 30 | | 10 | D | | | | | | | | | | | | | | |
6/17/19 13:23 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Hoffman Steve | NY | DOT | CEO | P | 16 | 1.08 | 0 | 15 | 0 | 26,483 | D | | | | | | | | | | | | | | |
6/17/19 13:20 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Korfin Michele Ilene | NY | O | COO | P | 5 | 1.03 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
6/17/19 13:17 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Galaini Barbara | NY | O | Principa | P | 10 | 1.00 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
6/17/19 13:15 | 6/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Taylor Ben R | NY | O | P,CFO | P | 10 | 1.01 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
2/19/19 16:50 | 2/14/19 | TYME | Health | Drug | Pharmaceutical Preparations | Michels Douglas A | NY | D | | P | 65 | 3.26 | 0 | 20 | 50 | 60 | D | | | | | | | | | | | | | | |